A systematic review of the impact of antifungal stewardship interventions in the United States

[1]  Brendan R. Jackson,et al.  Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. , 2018, Medical mycology.

[2]  D. Jacobs,et al.  Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study , 2017, Antimicrobial Agents and Chemotherapy.

[3]  C. Merchan,et al.  Role of postgraduate year 2 pharmacy residents in providing weekend antimicrobial stewardship coverage in an academic medical center. , 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  Christina A. Cuomo,et al.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  E. Bouza,et al.  The current treatment landscape: the need for antifungal stewardship programmes. , 2016, The Journal of antimicrobial chemotherapy.

[6]  E. Bouza,et al.  Conclusion and future perspectives on antifungal stewardship. , 2016, The Journal of antimicrobial chemotherapy.

[7]  A. Warris,et al.  The role of the multidisciplinary team in antifungal stewardship. , 2016, The Journal of antimicrobial chemotherapy.

[8]  Sarah K. Parker,et al.  Handshake Stewardship: A Highly Effective Rounding-based Antimicrobial Optimization Service , 2016, The Pediatric infectious disease journal.

[9]  S. Karanika,et al.  Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs , 2016, Antimicrobial Agents and Chemotherapy.

[10]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  James E. Levin,et al.  A Quality Assessment of a Collaborative Model of a Pediatric Antimicrobial Stewardship Program , 2016, Pediatrics.

[12]  K. Rand,et al.  Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. , 2016, Diagnostic microbiology and infectious disease.

[13]  W. Schaffner,et al.  Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014 , 2015, Open forum infectious diseases.

[14]  W. Melchers,et al.  Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Michael L Wilson,et al.  Long-Term Outcomes of an Antimicrobial Stewardship Program Implemented in a Hospital with Low Baseline Antibiotic Use , 2015, Infection Control & Hospital Epidemiology.

[16]  P. Cook,et al.  Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital. , 2015, International journal of antimicrobial agents.

[17]  S. Solomon,et al.  Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.

[18]  P. Pancholi,et al.  Improving the management of candidemia through antimicrobial stewardship interventions. , 2014, Diagnostic microbiology and infectious disease.

[19]  D. Newton,et al.  Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  D. Jacobs,et al.  Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[21]  M. F. Parry,et al.  Decreasing Clostridium difficile infections in surgery: impact of a practice bundle incorporating a resident rounding protocol. , 2013, Connecticut medicine.

[22]  T. Gandhi,et al.  Impact of an Antimicrobial Stewardship Program Comprehensive Care Bundle on Management of Candidemia , 2013, Pharmacotherapy.

[23]  Alison M Wilson,et al.  A matched-control evaluation of an antifungal bundle in the intensive care unit at a university teaching hospital , 2013, International Journal of Clinical Pharmacy.

[24]  David J Weber,et al.  Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[25]  Andrew Nguyen,et al.  Implementation of an antimicrobial stewardship program on the medical-surgical service of a 100-bed community hospital , 2012, Antimicrobial Resistance and Infection Control.

[26]  L. Fornecker,et al.  Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. , 2012, The Journal of antimicrobial chemotherapy.

[27]  C. Mcnulty,et al.  Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. , 2012, The Journal of antimicrobial chemotherapy.

[28]  J. Hossain,et al.  Benefits of a Pediatric Antimicrobial Stewardship Program at a Children's Hospital , 2011, Pediatrics.

[29]  S. Cosgrove,et al.  Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  A. Apisarnthanarak,et al.  Impact of Education and an Antifungal Stewardship Program for Candidiasis at a Thai Tertiary Care Center , 2010, Infection Control & Hospital Epidemiology.

[31]  A. Apisarnthanarak,et al.  Inappropriate Use of Antifungal Medications in a Tertiary Care Center in Thailand: A Prospective Study , 2008, Infection Control & Hospital Epidemiology.

[32]  M. Wagener,et al.  Antifungal Management Practices in Liver Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  L. Valiquette,et al.  Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  E. Bouza,et al.  Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety , 2012, Clinical transplantation.

[35]  H Mittermayer,et al.  Antimicrobial stewardship. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..